Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced the appointment of Edward L. Erickson to its board of directors. Mr. Erickson has also been appointed as a member of the company’s Governance and Nominating Committee.
